How To Start A Clinical Evaluation Report (CER) For Medical Devices

A Clinical Evaluation Report (CER) serves as the primary technical document proving a medical device’s safety and performance according to the European Medical Device Regulation (MDR) 2017/745. The process involves a rigorous cycle of clinical data collection, systematic literature review, and appraisal to demonstrate a favorable benefit-risk profile throughout the device lifecycle.

Foundational Requirements and Regulatory Preparation

Before initiating the CER, you must define the device scope and establish the clinical evaluation plan (CEP). The CEP acts as the roadmap, outlining the methodology for data collection and the specific clinical claims the device intends to support. A poorly scoped CER is the leading cause of Notified Body non-conformances during technical file audits.

• Essential Documentation:
  
  
  • Instructions for Use (IFU) and product brochures to establish intended purpose.
  • Design verification and validation (V&V) reports.
  • Risk management file (ISO 14971 compliant).
  • Post-market surveillance (PMS) data, if the device is already on the market.
• Mandatory Standards and Knowledge:
  
  
  • MDR 2017/745 Annex XIV (Clinical Evaluation).
  • MDCG 2020-1 (Guidance on Clinical Evaluation – Equivalence).
  • MDCG 2020-6 (Guidance on Sufficient Clinical Evidence).
• Budget and Duration Benchmarks:
  
  
  • Resource Allocation: Requires a multidisciplinary team (Regulatory Affairs, Clinical Scientist, Biostatistician).
  • Timeline: A standard initial CER development ranges from 3 to 6 months depending on the volume of clinical data and literature.

The Systematic Clinical Evaluation Execution Workflow

Step 1: Defining the Clinical Evaluation Plan (CEP)

The CEP is the foundational document that mandates the scope of the evaluation. You must clearly define the target population, anatomical sites, and the specific clinical claims the device makes.

1. Specify the Intended Purpose: This must match the labeling exactly.
2. Identify Target Populations: Include contraindications and clinical indications.
3. Establish Clinical Performance Metrics: Identify the specific endpoints (e.g., patient-reported outcome measures, survival rates, or technical performance indicators) that will measure success.

Warning: Never use clinical claims that are not supported by the existing risk management documentation or the physical design specifications of your device.

Step 2: Conducting the Systematic Literature Review (SLR)

The SLR identifies the current state-of-the-art (SOTA) for the medical condition treated by your device. This benchmark determines if your device performs effectively compared to existing treatment modalities.

1. Draft the Review Protocol: Define inclusion and exclusion criteria for study selection.
2. Database Selection: Use Embase, Medline, and Cochrane Library as primary sources.
3. Appraise Studies: Rank the quality of collected data based on hierarchy (e.g., Randomized Controlled Trials vs. retrospective cohorts).

Step 3: Clinical Data Appraisal and Analysis

Once you have the data, you must evaluate the validity and relevance of each study. If the data is derived from an equivalent device, you must provide a detailed justification for why the devices are equivalent in clinical, biological, and technical characteristics per MDR requirements.

1. Weight of Evidence: Determine the quality of the data based on sample size and study duration.
2. Benefit-Risk Analysis: Reconcile clinical findings with the risk management file.
3. Draft the Appraisal Report: Summarize why the data supports the safety of the device.

Step 4: Finalizing the Clinical Evaluation Report (CER)

The final document synthesizes all previous steps into a formal report. This document must be a living record, updated periodically based on Post-Market Clinical Follow-up (PMCF) activities.

1. Executive Summary: Provide an overview of the device and the conclusions reached.
2. Evidence Synthesis: Present the comparative data between your device and the SOTA.
3. Conclusion on Benefit-Risk: State clearly that the benefits outweigh the risks based on the gathered evidence.

Pro-Tip: Ensure the CER is signed by a qualified clinical evaluator with documented experience in the specific medical field of the device.

Clinical Data Source Comparison Matrix

Troubleshooting Common Regulatory Hurdles

• Failure Scenario: Inadequate Equivalence Justification
  
  
  • Root Cause: Failure to provide side-by-side technical, biological, and clinical parameter comparisons between the subject and equivalent devices.
  • Actionable Fix: Conduct a gap analysis of the device design specifications and provide a tabulated comparison confirming zero material or structural differences that impact clinical outcomes.
• Failure Scenario: Literature Search is Not Systematic
  
  
  • Root Cause: Using biased search terms or cherry-picking studies that only favor the device.
  • Actionable Fix: Document the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram to show the process of article screening, inclusion, and exclusion.
• Failure Scenario: Disconnected Risk Management and CER
  
  
  • Root Cause: The clinical performance metrics in the CER do not match the identified hazards in the ISO 14971 risk management file.
  • Actionable Fix: Perform a cross-verification mapping document to ensure every hazard listed in the risk file has a corresponding clinical mitigation or evidence point in the CER.

Frequently Asked Questions

What constitutes sufficient clinical evidence under the MDR?

Sufficient clinical evidence is defined as the amount and quality of data required to scientifically demonstrate that the device achieves its intended performance and that risks are acceptable. This usually requires a combination of clinical investigation data and clinical experience data from equivalent devices.

How often should a CER be updated?

A CER must be updated continuously as part of the device lifecycle. High-risk devices generally require annual updates, while lower-risk devices may follow the schedule outlined in the clinical evaluation plan, provided that new safety data is being monitored through PMS.

Can I use literature about a competitor's device in my CER?

Yes, you can use published data regarding equivalent devices to demonstrate the state-of-the-art and clinical performance, provided you can prove that your device is technically and biologically equivalent to the one referenced in the study.

What is the difference between a CEP and a CER?

The Clinical Evaluation Plan (CEP) is the prospective document that outlines the methodology, resources, and goals for the evaluation before it begins. The Clinical Evaluation Report (CER) is the retrospective document that presents the actual findings, analysis, and conclusions of the evaluation process.

Streamline Your Regulatory Compliance

Ensure your product reaches the market without delay by aligning your clinical evaluation strategy with current Notified Body expectations. Contact our team of experts today to audit your existing clinical documentation and prepare your devices for successful MDR certification.